mobile drug testing long island

USA Mobile Drug Testing of Central Long Island 516-802-3546 Legal NYS DNA Paternity Testing

Archive for the category “Drug & Alcohol Compliance”

Bath Salts now Illegal per President Obama in NYC and the USA

USA Mobile Drug Testing of Central Long Island can test for these illegal substances call 516-802-3546 for info.

The synthetic drug “bath salts” are now recognized as illegal substances under federal law.

President Barack Obama signed into law new legislation sponsored by U.S. Sen. Charles Schumer that will permanently ban the deadly chemical compounds marketed and sold as bath salts and incense in New York and the rest of the United States.

Schumer has fought to include three bills relating to bath salts, synthetic marijuana and synthetic hallucinogens as part of the Food and Drug Administration Safety and Innovation Act. Schumer and his colleagues were able to pass this ban over the strenuous objections of Sen. Rand Paul, R-Ky.

http://oneidadispatch.com/articles/2012/07/09/news/doc4ffb505937760752986101.txt

Another issue of Name that drug..increase your knowledge

Name That Drug: If it were an automobile, it would be a corvette!

This month’s drug is another one of those substances that owes its existence to serendipity. First experimented with in 1931, the chemical basis of this month’s drug was used as a starting point in the development of a new class of drugs designed to reduce muscle spasm. It was designed by a research chemist who was devoted to finding medicines that reduced the pain and suffering of children who were wheelchair bound by severe spastic conditions. In 1932, Otto Eislib had his drug. Or so he thought. Unfortunately, early experiments with this drug did not bear out its putative anti-spastic value. Like many other research chemicals of that same era, it was put out to pasture. But it was not over yet. Another enterprising researcher by the name of Otto Schaumann resurrected Eislib’s work and took to further examination of the drug. And low and behold, further study revealed that the drug possessed morphine-like qualities as an analgesic. Perhaps the most interesting facet of the drug at that point was that the drug was a synthesized chemical, a drug that was not extracted or refined from opium. With World War II fast approaching, this month’s drug held promise to combatants as an alternative analgesic to opium-based narcotics. It quickly underwent clinical study and evaluation.

email Central.LongIsland@usamdt.com  to see if you are correct. Read on for more clues:

It is quite apparent that this month’s drug is a narcotic analgesic drug. It’s a synthetic opiate to be more precise. And if it were an automobile, it would be a corvette. This descriptor belies the drug’s significant potency and power as an analgesic. Yet at the same time, the drug is speedy; it moves quickly through the central nervous system and the body. A significant clue as to its identity is that the drug’s half-life is three hours; its span of analgesic effects is less than other narcotics. This fact among others led to an early belief that this narcotic was “safer” and less prone to abuse than other drugs of its day. In particular, when compared to morphine, hydromorphone, and heroin, this month’s drug appeared to have fewer drawbacks. But like any narcotic that is an agonist of the mu opiate receptor, and this drug is a potent agonist at that, it poses a significant risk as a drug of abuse.

In fact, this month’s drug has had a rather checkered history as a recreational drug. It is a medication that is almost always diverted or stolen from pharmaceutical stores. It is produced as an oral tablet and as a solution for intramuscular injection. On the street, the drug can be crushed and snorted, or crushed and dissolved in water and then injected intravenously. But as recreational users have learned, the drug is caustic at the point of entry into the body. Bloody noses and ulcerating injection sites are often the leave behinds for this month’s drug. In fact, even medically necessary intramuscular injections of this drug can leave behind painful bumps and lumps in connective tissue. Abusers of the drug exhibit some very tell-tale signs of use. Because of its shorter half life, addicts of this drug are forced to use it more often and at shorter intervals. Addicts quickly realize that surface skin areas needed for injection get used up quickly. In relative short order, unseemly areas of raised, sore skin evidence the fact that an addict is injecting this drug.

As an analgesic, this month’s drug is mostly found in use in hospitals. It is relatively rare to find the drug in an outpatient setting. Despite the drug’s significant potency, it is not commonly found in pain management programs, although sometimes this drug is loaded into “pain pumps.” In those instances, the drug is delivered into spinal fluid by means of an intrathecal catheter; it is not administered intramuscularly. Because of its more frequent utilization in hospitals, it should not be a surprise that medical personnel often become ensnared by this drug. In the 1960s and 1970s, anesthesiologists wrestled with the drug. But with the emergence of the fentanyls in the 1980s, medical abuse and diversion of this drug rapidly tapered.

Called pethidine in many circles, this month’s drug is prescribed and abused worldwide. In the United States it is a Schedule II narcotic. Known for toxic effects caused by the metabolites of this drug, other less onerous drugs are used in its place. In-hospital patients often exhibit unpleasant side effects while being administered this drug. As a result, physicians have a tendency to use the drug intermittently; rarely is the drug used continually over a protracted period of time.

Known more commonly in the United States as meperidine, this drug costs approximately $25 for a 50 milligram pill on the street. In some larger American cities the drug can be purchased for half of that. Oddly enough, unlike most other drugs of its class, this drug has no recognized street name. It’s called by its registered product name.

Thank you MedTox journal for providing this informative “game”

Drug Free Work Place Policy Facts from USA Mobile Drug Testing

Do you have a formal written policy for your company?  If yes, when was the last time you had it reviewed?  If no, this is the first step in getting your company on the path to a Drug Free Workplace, congratulations! USAMDT of Central Long Island can assist you in putting together a comprehensive policy.

Financial Impact:  The US Coast Guard did a study stating each drug user cost them, on average, $6,600/year.   The Dept. of Labor did a similar study and states it costs them $7,000/year.  Let’s do the math:     1,000 employees – assuming 8% average drug use = 80 employees effected

80 x $6,600 = $528,000

That is over half a million dollars a year that you are wasting on workers’ comp claims, injuries, lost productivity, absenteeism and poor morale.

Testing Reasons: Pre-employment, reasonable suspicion, post-accident, random, follow up, return-to-duty and job site screening.  Fun facts: 50% of workers’ comp claims are abandoned when confronted with a drug test.  Today 1 of the key reasons for drug testing is to defend a workers’ comp claim.  And of course having a strong policy will also prevent you from paying an unemployment claim for an abuser.

Types of Samples: Hair, Urine, Saliva, Blood, Breath Alcohol and Oral Fluid.

Are you required to comply with Dept. of Transportation (DOT) Testing?  If yes, has your company distributed DOT compliant policies to all covered drivers?  Is your company conducting inquiries for alcohol and controlled substances information from previous employers?  Are you meeting the 2012 DOT Random Testing Rates for your specific DOT agency?  Do you know who your DER is?

What is screened in a standard 5 panel test? Amphetamines including Methamphetamine (AMP), Cocaine Metabolites (COC), Marijuana Metabolites (THC), Opiates including Codeine, Morphine and Heroin (OPI), Phencyclidine (PCP). What are some additional panels? Barbiturates (BAR), Benzodiazepines (BZO), Methadone (MTD), Propoxyphene (PPX), Methaqualone (MTQ), Methamphetamine (mAMP), Ecstasy (MDMA), Oxycodone (OXY).

What is Random Testing: Random testing is performed on an unannounced, unpredictable basis on employees whose identifying information (social or employee #) has been placed in a testing pool from which a scientifically arbitrary selection is made.  This selection is normally computer generated to ensure that it is indeed random and that each person of the workforce population has an equal chance of being selected for testing regardless of whether that person was recently tested or not.

Can Prescription Drugs Negatively Impact Employment?

In today’s world of routine drug testing in the workplace, employees are often concerned a prescription medication may affect a drug test.

A common concern may be “can I lose my job for taking it?”  Or “does my employer have a right to know what medication I am taking?”

Because some prescription medications can affect an employee’s ability to work safely, employers may have a legitimate interest in addressing them in their drug-free workplace policy.

“We are frequently approached by employers with questions about prescription drugs and how to handle them,” said Janet Matteo, Compliance Specialist with USA Mobile Drug Testing of Central Long Island, which provides on-site drug testing to companies.  “And fortunately, there are very specific guidelines on how to handle these situations, so that the employee is protected.”

Indeed, employers cannot discriminate in their hiring and firing practices based on an individual’s use of prescription medication for legitimate medical purposes, and such discrimination could be a violation of the Americans with Disabilities Act (ADA).

The ADA also prohibits an employer from asking disability-related questions unless they are job related and consistent with business necessity.

Services like USAMDT help companies to handle delicate drug testing matters correctly, as they limit a business’s exposure to liability for making non-compliant decisions.

As Matteo points out, there are a myriad of laws which protect the worker in situations like this, and “it’s best to let a qualified drug testing outfit oversee this very important aspect of a business.”

Post Navigation